CIK 0001446847
- Accelerated filer
- Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043404176
- Phone
- +1 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-20 | Dreyfus Andrew Director | Grant or award | +22,350 | 168,980 | ||
| 2023-06-20 | DENNER ALEXANDER J Director | Grant or award | +22,350 | 117,132 | ||
| 2023-06-20 | Currie Mark G Director | Grant or award | +22,350 | 544,108 | ||
| 2023-06-15 | Moukheibir Catherine Director | Grant or award | +1,586 | 102,613 | ||
| 2023-06-15 | DENNER ALEXANDER J Director | Grant or award | +1,359 | 94,782 | ||
| 2023-05-30 | MCCOURT Thomas A Chief Executive Officer | Sale 10b5-1 | −26,632 | $10.70 | $285K | 758,284 |
| 2023-05-22 | MCCOURT Thomas A Chief Executive Officer | Sale | −36,000 | $10.12 | $364K | 784,916 |
| 2023-05-22 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −10,324 | $10.12 | $104K | 321,131 |
| 2023-05-22 | Davis Andrew SVP, Chief Business Officer | Sale | −6,305 | $10.12 | $64K | 219,327 |
| 2023-05-08 | MCCOURT Thomas A Chief Executive Officer | Sale | −21,148 | $10.62 | $225K | 820,916 |
| 2023-03-27 | MCCOURT Thomas A Chief Executive Officer | Sale | −46,129 | $10.67 | $492K | 842,064 |
| 2023-03-15 | Moukheibir Catherine Director | Grant or award | +1,677 | 101,027 | ||
| 2023-03-15 | DENNER ALEXANDER J Director | Grant or award | +1,438 | 93,423 | ||
| 2023-03-08 | Silver Ronald Principal Accounting Officer | Grant or award | +35,620 | 134,111 | ||
| 2023-03-08 | Shetzline Michael CMO,SVP,Head-Res&Drug | Grant or award | +69,869 | 331,455 | ||
| 2023-03-08 | Shetzline Michael CMO,SVP,Head-Res&Drug | Grant or award · Performance-based Restricted Stock Units | +34,935 | 34,935 | ||
| 2023-03-08 | Rickard Jason SVP, Chief Operating Officer | Grant or award | +43,668 | 376,316 | ||
| 2023-03-08 | Rickard Jason SVP, Chief Operating Officer | Grant or award · Performance-based Restricted Stock Units | +21,834 | 21,834 | ||
| 2023-03-08 | John Minardo Chief Legal Officer | Grant or award | +65,502 | 199,240 | ||
| 2023-03-08 | John Minardo Chief Legal Officer | Grant or award · Performance-based Restricted Stock Units | +32,751 | 32,751 |
Page 8 of 14 · 274 trades